← Leaderboards
Santiago Andres Toledo Carrion
St. Edward'S University
$330,602
Attributed
$330,602
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $120K · FY2020–22$200K$150K$100K$50K$0
'20
'21
'22
Funding mix
By agency
NIH$330,602 · 1
By mechanism
SC2$330,602 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Analog”
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,023,002
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Terry Roemer · Prokaryotics, Inc.$14,198,753
Research focus
AnalogAnimalsApoptoticBacteriaBaseBindingBiological ModelsBiomimeticsBrain NeoplasmsCancer CellCarbon MonoxideCatalysisCell GrowthCell ProliferationCellsChemistryCobaltCodeComplexCopperDependenceDesignDioxygenasesActive Sites
Grant awards (3)
A Biomimetic Approach to Elucidating the Role in Disease of the Oxygenase Enzyme Acireductone Dioxygenase (ARD)$95,370
SC2 · FY2022 · GM · contact PI
A Biomimetic Approach to Elucidating the Role in Disease of the Oxygenase Enzyme Acireductone Dioxygenase (ARD)$119,971
SC2 · FY2021 · GM · contact PI
A Biomimetic Approach to Elucidating the Role in Disease of the Oxygenase Enzyme Acireductone Dioxygenase (ARD)$115,261
SC2 · FY2020 · GM · contact PI